GLP-1 Drug Shortages and Compounding July 2024 IPD has released a new podcast episode, GLP-1 Drug Shortages and Compounding," where Alyssa Guest, PharmD, discusses the glucagon-like peptide-1 (GLP-1) drugs and how interest in weight loss, viral social media posts, celebrity endorsements, illegitimate compounding, and drug shortages have all impacted access to GLP-1s
In recent years, drug-makers have been scrambling to develop more medications to add to this popular class of drugs (for example: retatrutide, danuglipron, or lotiglipron) to capitalize on the booming market for diabetes drugs that can also help people lose weight
Addisonian pigmentation the great mimicker a review
Neuropsychopharmacology 43, 459468
As demand grows, such expansions are crucial